This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.
People who inject drugs (PWID) are more likely to develop hepatitis C. The Centers for Disease Control and Prevention (CDC) points out that the virus can survive on equipment, such as needles, for up to three weeks. However, some of the different hepatitis C genotypes are more prominent in certain areas than others. A report published in the Journal of Hepatology uncovered the distribution of hepatitis C genotypes by continent in PWID.
Geert Robaeys, MD, PhD, and Rob Bielen, MD, from Ziekenhuis Oost-Limburg in Belgium, and colleagues, reviewed 48 studies from 48 countries. The data was collected from 1995 to 2005 from PWID. There are at least six different hepatitis C genotypes and over 50 subtypes, according to the CDC. The most prevalent genotypes were specified by continent:
- Globally: genotype 1
- Africa: genotypes 1a and 4
- Asia: genotypes 2 and 6
- Australia: genotypes 1 and 3
- Europe: genotypes 1, 3, and 4
- North America: genotypes 1 and 3
- South America: genotypes 1 and 3
“Overall, the most important differences comparing with the general population are a lower prevalence of genotype 1b in the PWID population and higher prevalence of genotype 1a and 3,” the researchers explained.
More specific findings revealed that although genotype 4 is known as the “African genotype,” there is little data on PWID – but the studies still found that it’s prominent in Africa. In addition, a few of the studies concluded that genotype 2 is highly prevalent in Japan.